R&D

OmniaMed Co., Ltd. opens up a new paradigm for the development of treatments using Nitric Oxide functionality.

Tech1

  • Primary cancer -> Migration through blood or lymph vessel -> Engraftment and growth of cancer cells on lymph node
  • Therefore, a strategy to kill cancer cells by delivering drugs to targets of lymph nodes is needed.
  • inhibit cancer metastasis by delivering NO donors to lymph nodes
  • Tech 1 is a technology that suppresses cancer metastasis by killing cancer cells by delivering and supplying NO to lymph nodes.